Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Nebulized Fentanyl in Patients With Mild-to-Moderate Interstitial Lung Disease and Chronic Dyspnea

NCT03018756 is registered in ClinicalTrials.gov with Dr. Denis O'Donnell as lead sponsor.

NCT NCT03018756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03018756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Nebulized Fentanyl in Patients With Mild-to-Moderate Interstitial Lung Disease and Chronic Dyspnea
Lead sponsor
Dr. Denis O'Donnell
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2017
Completion date
November 30, 2020
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial lung disease